Equities are facing one of the best backdrops for sustained gains next year. After a prolonged period of elevated risks (global trade war, COVID-19 pandemic, US election uncertainty, etc.), the outlook is clearing with the business cycle expanding and risks diminishing. We expect a “market nirvana” scenario for equities with the melt-up continuing into 1H21, driven by earnings recovery and…
“We have to acknowledge that overall breadth is weaker than it was during the biggest market drawdown during Q1...
The S&P 500 finished the month of June down -15%+ over the last 3 months and -20%+ over the...
It is not often that Finom Group is tasked with delivering a pessimistic interim outlook, but technicals are delivering...
“Good to know” does not mean what we know is altogether practical. Welcome back investors and traders, to more...
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
As the rally has rolled onward and upward, not everyone will achieve markedly satisfying results. Essentially, there will be...
Although the S&P 500 (SPX) would achieve a new, intraday all-time high this past week (Friday), it would fail...
The coming week will prove a meaningful earnings week, as the Mega-cap Growth companies will be reporting their quarterly...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
